Marijuana for Cancer Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-09-30

Study Completion Date

2004-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include nausea and/or vomiting.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

NCT05836857

Cancer

ACTIVE_NOT_RECRUITING

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

NCT06418204

Breast Carcinoma Colorectal Carcinoma Lung Non-Small Cell Carcinoma +2 more

RECRUITING

Patient Reported Symptom Control With THC or CBD Use

NCT04875286

Cancer-Associated Pain Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

ACTIVE_NOT_RECRUITING

A Study in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis Journal

NCT07089225

Cancer

NOT_YET_RECRUITING

Decreasing Long-term Opioid Use in Cancer Survivors

NCT05067556

Pain Chronic Pain Cancer Pain +1 more

SUSPENDED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To take part in this study, you must have ongoing cancer pain which is currently being treated with opioids. If you meet all the eligibility criteria you will be admitted to the General Clinical Research Center at San Francisco General Hospital for 9 days. The treatment consists of smoking one marijuana cigarette 3 times a day.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smoked Marijuana

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have ongoing cancer pain
* Be diagnosed with cancer and have at least a six month survival.
* Be on a stable dose of opioid medication for at least 2 weeks before enrollment.
* Have smoked marijuana on at least 6 occasions in their lifetime prior to enrollment.

Exclusion Criteria

You must not:

* Start chemotherapy, radiation or biphosphonates during the study, or have received any new intervention with any such agents within the past 4 weeks.
* Currently be using smoked tobacco products.
* Currently be in methadone treatment.
* Have smoked marijuana within 30 days of enrollment.
* Be diagnosed with diabetes mellitus.
* Have severe heart disease, uncontrolled hypertension, or lung disease.
* Currently be receiving treatment with corticosteroids.
* Be pregnant or breastfeeding.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No